•
Dec 31, 2023

BioLife Q4 2023 Earnings Report

Total Revenue
$32.7M
Previous year: $44.3M
-26.0%
EPS
-$0.21
Previous year: -$0.19
+10.5%
Gross margin
53%
Previous year: 30%
+76.7%
Adjusted gross margin
63%
Previous year: 32%
+96.9%
Operating loss
-$7.64M
Previous year: -$49.3M
-84.5%
Gross Profit
$8.34M
Previous year: $13.3M
-37.3%
Cash and Equivalents
$52.3M
Previous year: $64.1M
-18.4%
Free Cash Flow
$1.33M
Previous year: $3.41M
-61.0%
Total Assets
$413M
Previous year: $450M
-8.3%

BioLife

BioLife

BioLife Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income